Results 281 to 290 of about 268,841 (309)

A patent review of cyclin-dependent kinase 7 (CDK7) inhibitors (2018-2022)

Expert Opinion on Therapeutic Patents, 2023
Vladimir Kryštof, Radek Jordá, Václav Mik   +2 more
exaly  

Cell cycle regulatory molecules (cyclins, cyclin-dependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy?

European Heart Journal, 1999
G Brooks
exaly  

Cyclin-Dependent Kinase Inhibitor P27Kip1 Is Required for Mouse Mammary Gland Morphogenesis and Function

Journal of Cell Biology, 2001
CARLOS Arteaga, Arteaga CARLOS L
exaly  

Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer’s disease

Bioorganic and Medicinal Chemistry Letters, 2004
Christopher Helal, Frank Menniti
exaly  

The cyclin-dependent kinase inhibitor p21 is required for TGF-β1-induced podocyte apoptosis

Kidney International, 2005
Jeffrey Pippin
exaly  

Flavopiridol, the first cyclin-dependent kinase inhibitor to enter the clinic: current status

Expert Opinion on Investigational Drugs, 2000
L R Kelland
exaly  

Cyclin-dependent kinase 7: at the cross-roads of transcription, DNA repair and cell cycle control?

Current Opinion in Cell Biology, 1996
Erich Nigg
exaly  

The discovery of cyclin-dependent kinases

Nature Reviews Molecular Cell Biology
openaire   +2 more sources

A cyclin-dependent kinase family member (PHOA) is required to link developmental fate to environmental conditions in Aspergillus nidulans

EMBO Journal, 1998
Stephen Osmani
exaly  

Frequent overexpression of cyclin D2/cyclin-dependent kinase 4 in Wilms' tumor

Cancer Letters, 2005
Cecile Jeanpierre, Claudine Junien
exaly